Evidence map›Paper›PMID 30913332›Full record

ReviewChemistry (Weinheim an der Bergstrasse, Germany)2019

Mirror-Image Oligonucleotides: History and Emerging Applications.

Brian E Young, Nandini Kundu, Jonathan T Sczepanski

Abstract readReview
In one paragraph

Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Spiegelmer Aptamers: Innovative Approach in Breast Cancer.Breast cancer : basic and clinical research · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cross-chiral exponential amplification of an RNA enzyme.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. Article
  20. Synthesis of 2'-ACS omega · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian E YoungDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.
Nandini KunduDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.
Jonathan T SczepanskiDepartment of Chemistry, Texas A&M University, College Station, TX, 77843, USA.ORCID http://orcid.org/0000-0002-9275-2597

Funding

Mirror Image Aptamers: Next Generation RNA-Binding Reagents for Basic Research and Therapeutic ApplicationsR35GM124974 · NIGMS · TEXAS A&M UNIVERSITY · PI Jonathan Thomas Sczepanski · 2017 to 2026
$3.0M
A pooled analysis of risk factors of small intestine cancerR03CA150038 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOFFETTA, PAOLO, POTTER, JOHN D · 2010 to 2011
$173k
Cancer Prevention and Research Institute of Texas RR150038National Institute of General Medical Sciences R35GM124974NIGMS NIH HHS R35 GM124974
6 · The paper itself

Abstract

As chiral molecules, naturally occurring d-oligonucleotides have enantiomers, l-DNA and l-RNA, which are comprised of l-(deoxy)ribose sugars. These mirror-image oligonucleotides have the same physical and chemical properties as that of their native d-counterparts, yet are highly orthogonal to the stereospecific environment of biology. Consequently, l-oligonucleotides are resistant to nuclease degradation and many of the off-target interactions that plague traditional d-oligonucleotide-based technologies; thus making them ideal for biomedical applications. Despite a flurry of interest during the early 1990s, the inability of d- and l-oligonucleotides to form contiguous Watson-Crick base pairs with each other has ultimately led to the perception that l-oligonucleotides have only limited utility. Recently, however, scientists have begun to uncover novel strategies to harness the bio-orthogonality of l-oligonucleotides, while overcoming (and even exploiting) their inability to Watson-Crick base pair with the natural polymer. Herein, a brief history of l-oligonucleotide research is presented and emerging l-oligonucleotide-based technologies, as well as their applications in research and therapy, are presented.

Indexed as

AnimalsBase PairingBase SequenceBiosensing TechniquesDNAHumansNanostructuresNanotechnologyNucleic Acid ConformationOligonucleotidesRiboseRNAStereoisomerismDNAOligonucleotidesRiboseRNAchiralityDNAoligonucleotidesRNAspiegelmers

Identifiers

PMID30913332
PMCPMC6615976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.